A deeper evaluation of cytokeratin fragment 21-1 as a lung cancer tumor marker and comparison of different assays
Open Access
- 17 February 2025
- journal article
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 23
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 42 references indexed in Scilit:
- A novel electrochemical impedance immunosensor for the quantification of CYFRA 21-1 in human serumMicrochimica Acta, 2023
- Developing an understanding of artificial intelligence lung nodule risk prediction using insights from the Brock modelEuropean Radiology, 2022
- Ultrasensitive electrochemical detection of CYFRA 21-1 via in-situ initiated ROP signal amplification strategyAnalytica Chimica Acta, 2021
- User's guide to correlation coefficientsTurkish Journal of Emergency Medicine, 2018
- Toward Rapid, High-Sensitivity, Volume-Constrained Biomarker Quantification and Validation using Backscattering InterferometryAnalytical Chemistry, 2014
- A novel detection method of non–small cell lung cancer using multiplexed bead-based serum biomarker profilingThe Journal of Thoracic and Cardiovascular Surgery, 2012
- A repeated measures concordance correlation coefficientStatistics in Medicine, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell linesInternational Journal of Cancer, 2000
- CYFRA 21-1: A new marker in lung cancerCancer, 1993